Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Food ; 13(6): 1443-50, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20874227

ABSTRACT

Several health benefits, including protection from tumors at various anatomic sites, such as the lungs, stomach, and prostate gland, have been attributed to tomatoes and tomato-based products. Among tomato carotenoids, lycopene is the most active antioxidant, although it has many other biological effects, but data on its antimutagenic effects are scarce and often discrepant. The aim of our work was to determine the protective effects of lycopene, with regard to mutagenicity, via two indirect mutagens/carcinogens-2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and aflatoxin B1 (AFB1) and the direct mutagen/carcinogen N-nitroso-N-methylurea (MNU)--using the Ames and micronucleus tests. The significant, dose-dependent, antimutagenic effects of two concentrations of lycopene (30 µg and 300 µg per plate) were demonstrated at various concentrations of both AFB1 and IQ in two strains of Salmonella typhimurium (TA98 and TA100). The protective effects of lycopene relative to MNU were lower in comparison to its protective effects relative to AFB1 and IQ. Mice treated for 3 days with different doses of lycopene (either 25 or 50 mg/kg of body weight) prior to administration of individual mutagens resulted in a significant reduction of micronuclei numbers in the micronucleus test. Tomato purée (tested using the Ames test and AFB(1)) revealed a much stronger, dose-dependent, antimutagenic effect compared with corresponding doses of pure lycopene. Results indicate that lycopene has antimutagenic effects, although the effects are lower than that of tomato purée, which contains a complex mixture of bioactive phytochemicals. The antimutagenic effect is connected with the chemoprotective role of lycopene, tomatoes, and tomato products in the prevention of carcinogenesis.


Subject(s)
Antimutagenic Agents/pharmacology , Carotenoids/pharmacology , Fruit , Solanum lycopersicum , Aflatoxin B1/antagonists & inhibitors , Aflatoxin B1/metabolism , Aflatoxin B1/toxicity , Animals , Antimutagenic Agents/analysis , Antimutagenic Agents/chemistry , Bone Marrow Cells/drug effects , Carcinogens/antagonists & inhibitors , Carcinogens/metabolism , Carcinogens/toxicity , Carotenoids/analysis , Dose-Response Relationship, Drug , Fruit/chemistry , Liver/metabolism , Lycopene , Solanum lycopersicum/chemistry , Male , Methylnitrosourea/toxicity , Mice , Mice, Inbred BALB C , Micronucleus Tests , Mutagenicity Tests , Mutagens/metabolism , Mutagens/toxicity , Neoplasms/prevention & control , Quinolines/antagonists & inhibitors , Quinolines/metabolism , Quinolines/toxicity , Rats , Rats, Wistar , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics
2.
Cent Eur J Public Health ; 17(2): 86-92, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19662826

ABSTRACT

Using the Ames bacterial mutagenicity test, the comet assay, and an in vivo micronucleus test, we investigated the effect of the chemoprotective substance phenethyl isothiocyanate (PEITC) on the mutagenic activity of indirect-acting mutagens and carcinogens aflatoxin B1 (AFB1) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), and direct-acting mutagen and carcinogen N-nitroso-N-methylurea (MNU). In the Ames test, the antimutagenic activity of PEITC was studied in the concentration range 0.3-300 microg/plate. PEITC at concentrations of 0.3, 3 and 30 microg/plate reduced dose-dependently mutagenicity of AFB1 and IQ in both S. typhimurium TA98 and TA100 strains. In the case of the direct mutagen MNU, the antimutagenic effect of PEITC was detected only at concentration of 30 microg/plate in the strain TA100. The PEITC concentration 300 microg/plate was toxic in the Ames test. The 24 h pre-treatment of HepG2 cells with PEITC at concentration 0.15 microg/ml resulted in a significant decrease of DNA breaks induced by MNU at concentrations 0.25 and 0.5 mM. Although a trend towards reduced strand break level were determined also at PEITC concentrations 0.035 and 0.07 microg/ml it did not reach the statistical significance. No effect, however, of PEITC on IQ-induced DNA breaks was observed. Chemopreventive effect of PEITC was revealed also in vivo. Pretreatment of mice with PEITC concentrations of 25 and 12.5 mg/kg b.w. administered to mice in three daily doses resulted in reduction of micronucleus formation in mice exposed to all three mutagens under study, with statistically significant effect at concentration of 25 mg/kg. Results of this study indicate that the strong PEITC antimutagenic properties may have an important role in the prevention of carcinogenesis and other chronic degenerative diseases that share some common pathogenetic mechanisms.


Subject(s)
Antimutagenic Agents/pharmacology , Isothiocyanates/pharmacology , Aflatoxin B1/toxicity , Animals , Antimutagenic Agents/administration & dosage , Carcinogens/toxicity , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Isothiocyanates/administration & dosage , Male , Methylnitrosourea/toxicity , Mice , Mice, Inbred BALB C , Mutagenicity Tests , Mutagens/toxicity , Quinolines/toxicity , Salmonella typhimurium
3.
Mutat Res ; 608(1): 49-57, 2006 Sep 19.
Article in English | MEDLINE | ID: mdl-16807075

ABSTRACT

We investigated single-strand breaks and endonuclease III-sensitive sites in DNA along with gamma-irradiation-specific DNA-repair activity in hepatocytes and frequencies of micronuclei in polychromatic bone-marrow erythrocytes of male NMRI mice (2 months old, weight 30-35 g) during sub-acute inhalation exposure to 1,3-butadiene (28 days, 500 mg/m3) and up to 28 days after the exposure. Concentrations of 1,3-butadiene in blood, an indicator of internal exposure, moderately increased during the exposure period. The most interesting finding was that gamma-irradiation-specific DNA-repair activity gradually increased during exposure, being significantly higher compared with control levels on days 7 and 28 of exposure (P = 0.005 and 0.035, respectively), reaching a maximum on day 1 after the termination of exposure (P = 0.003) and then returning to control levels. A significant correlation between gamma-irradiation-specific DNA-repair activity and the concentration of 1,3-butadiene in blood (R = 0.866, P = 0.050) supports a possible induction of DNA-repair activity by the exposure to 1,3-butadiene and formation of its metabolites. The initial increase in micronucleus frequency (micronuclei per 1000 cells) in the exposed mice continuously decreased from 20.4 +/- 5.1 (day 3) to 15.1 +/- 3.2 (day 28) within the exposure period, and subsequently from 12.4 +/- 5.1 to 4.6 +/- 1.6 in the period following termination of the 1,3-butadiene exposure, while micronucleus frequencies in control animals were significantly lower (from 1.7 +/- 1.5 to 4.2 +/- 0.8).


Subject(s)
Butadienes/toxicity , DNA Damage , DNA Repair , Micronuclei, Chromosome-Defective , Administration, Inhalation , Animals , Bone Marrow Cells/cytology , Butadienes/administration & dosage , Butadienes/blood , Comet Assay , Deoxyribonuclease (Pyrimidine Dimer)/metabolism , Erythrocytes/cytology , Escherichia coli Proteins/metabolism , Gamma Rays , Hepatocytes/metabolism , Male , Mice , Regression Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...